SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Perry who wrote (948)4/3/1998 2:40:00 PM
From: Brian Malloy  Read Replies (2) | Respond to of 9523
 
As the link below shows, even small companies in the ED market can test their products utilizing large numbers. The following is for MUSE produced by VIVUS (VVUS)

The New England Journal of Medicine -- January 2, 1997 -- Volume 336, Number 1
Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil

Methods. Alprostadil was delivered transurethrally in a double-blind, placebo-controlled study of 1511 men, 27 to 88 years of age, who had chronic erectile dysfunction from various organic causes.
nejm.org



To: Perry who wrote (948)4/3/1998 4:06:00 PM
From: WillDearborn  Respond to of 9523
 
Perry,

BTW, I am also an investor in PFE, purchased 400 shares a year ago in the upper 40 range for my 401(k) account. Sold 200 shares early this week, returning my $ original investment and leaving me with 200 shares in this well run company. I still like PFE and expect continued long term growth, both in revenues, profits and shareholder returns.

I posted the previous note about other ED drugs, specifically about MCHM for two reasons, one because I am an investor in MCHM and two, there is more to PFE than just Viagra. The whole media hype around this new drug sounds like an infomercial to me. I wanted to post a different point of view with some facts.

Thanks for the kind response, as there are other threads in SI that would have jumped all over a post such as mine.

wd